Article

PD-1 Inhibitors are a game changer

Author(s):

Guest

Michael Wong, melanoma oncologist and CURE advisory board member, explains how recent studies are targeting the PD-1 pathway and describes why there is so much excitement surrounding this new class of immunotherapy.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate cancer.
Image of man.
Image of Crispino
Image of Dr. Reznick
Picture of Joy Anderson
Some patients with relapsed/refractory diffuse large B-cell lymphoma whose disease progressed after CAR-T cell therapy, responded to odronextamab.
Anne M. Reb is a nurse practitioner with City of Hope.
Image of woman with brown hair.
Image of man with black hair.
Image of bald man.
Related Content
From left: JILL REESE, M.S., APRN, AGCNS-BC, OCN, and SUSIE MALONEY, M.S., APRN, AOCN, AOCNS
April 27th 2025

Healer, Mentor and Leader

Susie Maloney, M.S., APRN, AOCN, AOCNS
Reflecting upon my relationship with Jill over the past 25 years, I am in awe of all she has accomplished.
The Importance of Spotting Endometrial Cancer
March 18th 2025

The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.
Sign outside the FDA offices.
April 26th 2025

FDA OKs Investigational New Drug Application for VS-7375 in Solid Tumors

Spencer Feldman
Verastem will launch a U.S. phase 1/2a trial of oral KRAS G12D inhibitor VS-7375 after FDA IND clearance, with data to be presented at ASCO 2025.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
September 20th 2024

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
Dr. Brian Czerniecki, of Moffitt Cancer Center, led a CURE Educated Patient® Updates in Metastatic Breast Cancer event, and provided subsequent updates: © stock.adobe.com.
April 25th 2025

New Options for ER+ Breast Cancer Spotlighted at Patient Event

Alex Biese
Dr. Brian Czerniecki, of Moffitt Cancer Center, led a CURE Educated Patient® Updates in Metastatic Breast Cancer event, and provided subsequent updates.
Illustration of georgia.
April 25th 2025

A Digital Detox for the Soul with Lynch Syndrome

Georgia Hurst
Unplugging from digital noise helped me find peace, clarity and room for growth during a season of emotional and mental renewal.